Category Archives:

LONDON (Reuters) - Major Glencore shareholder BlackRock Inc was among investors to reject the mining giant's climate progress report at its annual meeting in May, citing inconsistencies, a voting disc...

WASHINGTON (Reuters) - Microsoft says the Chinese hack of U.S. government officials stemmed from compromise of a Microsoft engineer's corporate account. In a blog post published on Wednesday, Microsof...

MEXICO CITY (Reuters) - Tesla is eyeing 2026 or 2027 to potentially begin production at a major new factory planned for Mexico, according to a report published in Mexican daily Reforma on Wednesday. T...

PEORIA, Ill. – Three people listed in court documents as homeless have been charged in connection with animals found abandoned on a boat along the Illinois River back in July. A Peoria County gr...

By Marcela Ayres and Bernardo Caram BRASILIA (Reuters) - Even as Brazil's economic growth blew past expectations in the first half of this year, tax revenue has tumbled, underscoring doubts about the ...

NEW YORK (Reuters) - Latin American is at the crossroads of climate finance and supply chain rebuilding, and it could benefit from putting the correct policies in place, according to a G30 report on t...

(Reuters) - IBM said on Wednesday it is notifying customers of Janssen CarePath, a Johnson & Johnson unit, of a "data incident" involving unauthorized access of personal information. The personal info...

By Stephen Nellis (Reuters) - The U.S. Commerce Department should end all technology exports to Huawei and China's top semiconductor firm following the discovery of new chips in Huawei phones that may...

By Ann Saphir and Michael S. Derby (Reuters) - U.S. economic growth was "modest" in recent weeks, job growth was "subdued," and inflation slowed in most parts of the country, a Federal Reserve report ...

By Brendan Pierson (Reuters) - Bristol Myers Squibb has been accused in a new lawsuit of using fraudulent patents and other illegal tactics to maintain its monopoly on blockbuster blood cancer drug Po...